Silk Road Medical, which sells medical devices to treat carotid artery disease, raised $120 million by offering 6 million shares at $20, the high end of the range of $19 to $20. Silk Road Medical plans to list on the Nasdaq under the symbol SILK. J.P. Morgan and BofA Merrill Lynch acted as lead managers on the deal.
